4.7 Review

Microfluidic technologies for drug discovery and development: friend or foe?

Journal

TRENDS IN PHARMACOLOGICAL SCIENCES
Volume 42, Issue 7, Pages 518-526

Publisher

CELL PRESS
DOI: 10.1016/j.tips.2021.04.009

Keywords

-

Funding

  1. Canada Research Chairs program
  2. Michael Smith Foundation Health Research Scholar award
  3. Pacific Alzheimer Research Foundation

Ask authors/readers for more resources

Introducing the advantages and disadvantages, showcasing applications in drug discovery and development, discussing the transfer from academia to industry, and exploring the potential for a paradigm shift in drug discovery and development with microfluidic technologies.
There is a point in the evolution of every new technology when questions need to be asked regarding its usefulness and impact. Although microfluidic technologies have drastically decreased the scales at which laboratory processes can be performed and have enabled scientific advances that would have otherwise not been possible, it is time to consider whether these technologies are more disruptive than enabling. Here, my aims are to introduce researchers in the broad fields of drug discovery and development to the advantages and disadvantages of microfluidic technologies, to highlight current work showing how microfluidic technologies can be used at different stages in the drug discovery and development process, to discuss how we can transfer academic breakthroughs in the field of microfluidic technologies to industrial environments, and to examine whether microfluidic technologies have the potential to cause a fundamental paradigm shift in the way that drug discovery and development occurs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available